Information Links
Diabetes news

Stop SGLT2 inhibitors and monitor ketones in hospitalised patients, says MHRA
SGLT2 inhibitor treatment should be interrupted in...

First oral hypoglycaemic licensed for add-on therapy in type I diabetes
The SGLT2 inhibitor dapagliflozin (Forxiga) can now...

New MIMS table helps GPs adjust antidiabetic doses in renal impairment
Prescribers can now consult a handy MIMS table to check...

Fingerprick-free glucose monitoring system available on the NHS
A glucose monitoring system that does not require regular...

New combination tablet for type II diabetes
Qtern contains a fixed-dose combination of saxagliptin...

Renal impairment warnings relaxed for metformin products
Metformin-containing products can now be used in patients...

SGLT2 inhibitors endorsed for NHS use as monotherapies
Canagliflozin, dapagliflozin and empagliflozin have...

Pictorial guide to diabetes devices now available on MIMS website
GPs and MIMS subscribers can now view images and key...

Foot care reminder for canagliflozin prescribing
Healthcare professionals have been reminded of the...

New advice on diabetic ketoacidosis risk with SGLT2 inhibitors
Measures to reduce the risk of rare diabetic ketoacidosis...

MIMS publishes summary of new NICE diabetes guidance
A quick-reference MIMS summary of the recently revised...

Albiglutide: new once-weekly GLP-1 receptor agonist for diabetes
Eperzan (albiglutide) is indicated for the treatment...

GPs warned of potential insulin shortages
Sanofi has announced a possible supply shortage of...

New for diabetes: empagliflozin/metformin fixed-dose combination
The SGLT2 inhibitor empagliflozin (Jardiance) is now...

First biosimilar insulin launches
Abasaglar is a new biosimilar version of the long-acting...

New high-strength insulin glargine formulation
Toujeo (insulin glargine) is a 300 units/ml formulation...

SGLT2 inhibitors: risk of diabetic ketoacidosis
Patients receiving SGLT2 inhibitors (canagliflozin,...
MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.